Abstract
BackgroundUstekinumab blocks the action of IL-12 and IL-23 by interfering with binding of the p40 subunit to the IL-12Rβ1 subunit used by IL-12 and IL-23 receptors. IL-12 and IL-23 are...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have